2019 Archive

Outreach

Assessing global pediatric cancer: Finding out what we don’t know and reaching more children

Nickhill Bhakta, MD, MPH

To improve the survival rate of global pediatric cancer, we must first find out how to reach many children who aren't a part of a national or regional registry.

Research

Learn the basics of CAR T-cell therapy and how it is being used in the SJCAR19 clinical trial at St. Jude

Aimee Talleur, MD

Learn the basics of CAR T-cell immunotherapy and how it is being used in the SJCAR19 clinical trial for acute lymphoblastic leukemia.

Clinical

Managing pain without enabling opioid addiction

Doralina Anghelescu, MD

How do physicians manage their patients’ pain in the context of the current opioid crises? Read how this physician helped a patient.

Research

A moving target: Taking aim at the shift and drift of influenza viruses

Daniel Darnell

How close are we to a flu pandemic? Read how it could happen and what researchers are doing to prevent it.

Research

Blazing through new territory to fight a devastating neurodegenerative disease

St. Jude Communications Department

Read how researchers have found a path to control coenzyme A and possibly prevent a devastating neurodegenerative disease.

Outreach

Why I strive to be like my mentor

Dillon Robinson

Read how mentoring transformed a small-town college student into an epidemiologist.

Investigator Insights

Postdoc survival guide: On the road to big discovery, you’re allowed to stumble on your first steps

Anthony Zamora, PhD

New lab, new investigators, new personalities, new team – learn how to make it in your first year as a postdoc.

Research

Can obesity give influenza more time to spread and make vaccines less effective?

Stacey Schultz-Cherry, PhD

St. Jude researchers, led by Dr. Stacey Schultz-Cherry, are asking questions about potential association between flu severity and the obesity epidemic.

Research

Gut microbiome sequencing opens new possibilities for predicting infection in leukemia patients

St. Jude Communications Department

Researchers identify intestinal microbiota that may predict infection risk during chemotherapy in pediatric ALL patients. Learn about the gut microbiome.

Research

New drug for a rare disorder: How will Gamifant’s approval affect HLH treatment?

Melissa Hines, MD

HLH, a rare disorder of the immune system, is caused by a buildup of proteins responding to infection. Read about a new treatment that limits that buildup.